NCT04628312 is a NA clinical trial of Static footprint in Myofascial Pain Syndrome, sponsored by Mayuben Private Clinic.

Who is sponsoring NCT04628312?

NCT04628312 is sponsored by Mayuben Private Clinic.

What drugs are being tested in NCT04628312?

Interventions in NCT04628312: Static footprint.

What condition does NCT04628312 study?

NCT04628312 studies Myofascial Pain Syndrome, Foot Diseases.

Is NCT04628312 still recruiting?

NCT04628312 is currently completed. Last updated 3 December 2020.

Last reviewed 2020-12-03 · How we verify

NCT04628312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Foot Plantar Pressure Changes After Plantar Dry Needling

Completed NA Last updated 3 December 2020

What this trial tests

NA trial testing Static footprint in Myofascial Pain Syndrome in 18 participants. Completed in 2 December 2020.

Timeline

20 November 2020

Primary endpoint
27 November 2020

2 December 2020

Quick facts

Lead sponsor	Mayuben Private Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	18
Start date	20 November 2020
Primary completion	27 November 2020
Estimated completion	2 December 2020
Sites	1 location across Spain

Drugs / interventions tested

Static footprint

Conditions studied

Myofascial Pain Syndrome — all drugs for Myofascial Pain Syndrome →
Foot Diseases — all drugs for Foot Diseases →

Sponsor

Mayuben Private Clinic

Who can join

Adults 18 to 40, any sex, with Myofascial Pain Syndrome or Foot Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical trial is to check the effects of dry needling in the Flexor digitorum Brevis. Twenty healthy subjects wil be recruited for a quasi-experimental study. Participants will be from 18 to 40 years old, not obese. Participants will be measured before and after bilateral dry neddling in Flexor digitorum Brevis. The investigators will measure static footprint variables. The footprint variables will be divided in bilateral rear foot, bilateral midfoot, bilateral fore foot.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Flexor Digitorum Brevis Muscle Dry Needling Changes Surface and Plantar Pressures: A Pre-Post Study.
Martínez-Jiménez EM, Losa-Iglesias ME, Antolín-Gil MS, López-López D, et al · · 2021 · cited 8× · PMID 33451013 · DOI 10.3390/life11010048

Verify or expand the search:

Other recruiting trials for Myofascial Pain Syndrome

Currently open trials in the same condition.

NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
NCT07045324 — Effect of Vagus Nerve Stimulation on Trapezius Trigger Point · NA · active not recruiting

Other Mayuben Private Clinic trials

Trials by the same sponsor.

NCT06715904 — Sex Differences in Morton's Extension Application on Plantar Pressure Distribution in Different Foot Regions in Female a · NA · completed
NCT06514404 — Comparative Study of Empathy and Anxiety in the Different Academic Years, at the Beginning of Academic Year and Exam Per · not yet recruiting
NCT06526715 — Balance Effects of Morton´s Extension in Flat Foot · NA · completed
NCT06499545 — Plantar Pressures After Pressure Release of the Flexor Digitorum Brevis Muscle Versus a Non-emission Laser. · NA · completed
NCT06499493 — Effects of Myofascial Induction Pressure Pain Threshold in Trigger Points of the Proximal Muscles of Gastrocnemius · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04628312 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayuben Private Clinic
Last refreshed: 3 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04628312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing